Literature DB >> 29442270

Spatial distribution bias in subject-specific abnormalities analyses.

Andrew B Dodd1, Josef M Ling1, Edward J Bedrick2, Timothy B Meier3, Andrew R Mayer4,5,6.   

Abstract

The neuroimaging community has seen a renewed interest in algorithms that provide a location-independent summary of subject-specific abnormalities (SSA) to assess individual lesion load. More recently, these methods have been extended to assess whether multiple individuals within the same cohort exhibit extrema in the same spatial location (e.g., voxel or region of interest). However, the statistical validity of this approach has not been rigorously established. The current study evaluated the potential for a spatial bias in the distribution of SSA using several common z-transformation algorithms (leave-one-out [LOO]; independent sample [IDS]; Enhanced Z-Score Microstructural Assessment of Pathology [EZ-MAP]; distribution-corrected z-scores [DisCo-Z]) using both simulated data and DTI data from 50 healthy controls. Results indicated that methods which z-transformed data based on statistical moments from a reference group (LOO, DisCo-Z) led to bias in the spatial location of extrema for the comparison group. In contrast, methods that z-transformed data using an independent third group (EZ-MAP, IDS) resulted in no spatial bias. Importantly, none of the methods exhibited bias when results were summed across all individual elements. The spatial bias is primarily driven by sampling error, in which differences in the mean and standard deviation of the untransformed data have a higher probability of producing extrema in the same spatial location for the comparison but not reference group. In conclusion, evaluating SSA overlap within cohorts should be either be avoided in deference to established group-wise comparisons or performed only when data is available from an independent third group.

Entities:  

Keywords:  Fractional anisotropy; Neuroimaging; Overlap; Simulations; Single-subject

Mesh:

Year:  2018        PMID: 29442270      PMCID: PMC6089678          DOI: 10.1007/s11682-018-9836-x

Source DB:  PubMed          Journal:  Brain Imaging Behav        ISSN: 1931-7557            Impact factor:   3.978


  12 in total

1.  Longitudinal assessment of white matter abnormalities following sports-related concussion.

Authors:  Timothy B Meier; Maurizio Bergamino; Patrick S F Bellgowan; T K Teague; Josef M Ling; Andreas Jeromin; Andrew R Mayer
Journal:  Hum Brain Mapp       Date:  2015-12-10       Impact factor: 5.038

2.  Potholes and molehills: bias in the diagnostic performance of diffusion-tensor imaging in concussion.

Authors:  Richard Watts; Alex Thomas; Christopher G Filippi; Joshua P Nickerson; Kalev Freeman
Journal:  Radiology       Date:  2014-03-14       Impact factor: 11.105

3.  Comparative neuropsychiatry: white matter abnormalities in children and adolescents with schizophrenia, bipolar affective disorder, and obsessive-compulsive disorder.

Authors:  T White; C Langen; M Schmidt; M Hough; A James
Journal:  Eur Psychiatry       Date:  2014-12-12       Impact factor: 5.361

4.  Spatial characteristics of white matter abnormalities in schizophrenia.

Authors:  Tonya White; Stefan Ehrlich; Beng-Choon Ho; Dara S Manoach; Arvind Caprihan; S Charles Schulz; Nancy C Andreasen; Randy L Gollub; Vince D Calhoun; Vincent A Magnotta
Journal:  Schizophr Bull       Date:  2012-09-16       Impact factor: 9.306

5.  White matter compromise in veterans exposed to primary blast forces.

Authors:  Katherine H Taber; Robin A Hurley; Courtney C Haswell; Jared A Rowland; Susan D Hurt; Cory D Lamar; Rajendra A Morey
Journal:  J Head Trauma Rehabil       Date:  2015 Jan-Feb       Impact factor: 2.710

6.  White matter abnormalities are associated with chronic postconcussion symptoms in blast-related mild traumatic brain injury.

Authors:  Danielle R Miller; Jasmeet P Hayes; Ginette Lafleche; David H Salat; Mieke Verfaellie
Journal:  Hum Brain Mapp       Date:  2015-10-24       Impact factor: 5.038

7.  Whole brain approaches for identification of microstructural abnormalities in individual patients: comparison of techniques applied to mild traumatic brain injury.

Authors:  Namhee Kim; Craig A Branch; Mimi Kim; Michael L Lipton
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

8.  The nature of white matter abnormalities in blast-related mild traumatic brain injury.

Authors:  Jasmeet P Hayes; Danielle R Miller; Ginette Lafleche; David H Salat; Mieke Verfaellie
Journal:  Neuroimage Clin       Date:  2015-04-09       Impact factor: 4.881

9.  Increased gray matter diffusion anisotropy in patients with persistent post-concussive symptoms following mild traumatic brain injury.

Authors:  Sylvain Bouix; Ofer Pasternak; Yogesh Rathi; Paula E Pelavin; Ross Zafonte; Martha E Shenton
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

10.  Visualising inter-subject variability in fMRI using threshold-weighted overlap maps.

Authors:  Mohamed L Seghier; Cathy J Price
Journal:  Sci Rep       Date:  2016-02-05       Impact factor: 4.379

View more
  2 in total

1.  Resting-State fMRI Metrics in Acute Sport-Related Concussion and Their Association with Clinical Recovery: A Study from the NCAA-DOD CARE Consortium.

Authors:  Timothy B Meier; Monica Giraldo-Chica; Lezlie Y España; Andrew R Mayer; Jaroslaw Harezlak; Andrew S Nencka; Yang Wang; Kevin M Koch; Yu-Chien Wu; Andrew J Saykin; Christopher C Giza; Joshua Goldman; John P DiFiori; Kevin M Guskiewicz; Jason P Mihalik; Alison Brooks; Steven P Broglio; Thomas McAllister; Michael A McCrea
Journal:  J Neurotrauma       Date:  2019-09-18       Impact factor: 5.269

2.  Advanced biomarkers of pediatric mild traumatic brain injury: Progress and perils.

Authors:  Andrew R Mayer; Mayank Kaushal; Andrew B Dodd; Faith M Hanlon; Nicholas A Shaff; Rebekah Mannix; Christina L Master; John J Leddy; David Stephenson; Christopher J Wertz; Elizabeth M Suelzer; Kristy B Arbogast; Timothy B Meier
Journal:  Neurosci Biobehav Rev       Date:  2018-08-09       Impact factor: 8.989

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.